Comparison of Three Sample Size Calculation Methods for Non-Inferiority Vaccine Trials With Multiple Continuous Co-Primary Endpoints

Human Vaccines and Immunotherapeutics - United States
doi 10.1080/21645515.2018.1514221
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Bayesian Sample‐size Determination Methods Considering Both Worthwhileness and Unpromisingness for Exploratory Two‐arm Randomized Clinical Trials With Binary Endpoints

Pharmaceutical Statistics
StatisticsProbabilityPharmacology
2019English

Sample Size Calculation for Multicentre Efficacy Trials of Blood-Stage Malaria Antigens

Malaria Journal
ParasitologyInfectious Diseases
2013English

Planning and Interpreting the Sample Size of Trials With Multiple Outcomes

Journal of Orthodontics
Orthodontics
2019English

Evaluation of Operational Chronic Infection Endpoints for HCV Vaccine Trials

Contemporary Clinical Trials
MedicinePharmacology
2008English

Statistical Considerations in the Design and Analysis of Non-Inferiority Trials With Binary Endpoints in the Presence of Non-Adherence: A Simulation Study

Wellcome Open Research
BiochemistryMedicineGeneticsMolecular Biology
2019English

Design and Endpoints for Clinical Trials in Primary Sclerosing Cholangitis

Hepatology
MedicineHepatology
2018English

The Limitations of Equivalence and Non-Inferiority Trials

Psychological Medicine
PsychiatryMental HealthApplied Psychology
2018English

Non-Inferiority Drug Trials Fail to Report Adequate Methodological Detail (An Assessment of Non-Inferiority Trials From 2010-2015)

Journal of Clinical Epidemiology
Epidemiology
2019English

Sample-Size Needs for Forestry Herbicide Trials

Canadian Journal of Forest Research
ForestryPlanetary ChangeGlobalEcology
1993English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy